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Protect Babies from Life-threatening Bleeding — 
Talk to Expectant Parents about the Benefits of the 
Vitamin K Shot for Newborns 
Although the Vitamin K shot is safe and, as recommended 
by the American Academy of Pediatrics, has been 
routinely given to newborns at birth since 1961, some 
parents refuse the shot due to myths and misperceptions 
about its safety. This puts babies at risk for dangerous 
bleeding which can lead to brain damage and even 
death. As a healthcare provider, you are in a unique 
position to debunk these myths and misperceptions. 
Provide reliable information to parents about the 
benefits of Vitamin K so that they can make the most 
informed choices about their child’s medical care and 
protect them from potentially devastating health 
consequences.
 y Talk to expectant parents about the benefits of a 
single Vitamin K shot after birth before they get to the 
delivery room. 
 y Encourage expectant parents to protect their newborn 
by making sure he or she gets the shot after birth. 
Purpose of Vitamin K
Vitamin K refers to a group of structurally similar fat-
soluble molecules that are primarily involved in the 
synthetic pathways of a number of clotting factors. Vitamin 
K is also involved in bone metabolism. 
Sources of Vitamin K
Adults get vitamin K from food — mainly leafy green 
vegetables — and from bacterial synthesis in the gut. 
Babies have very little vitamin K in their bodies at birth 
because only small amounts of the vitamin pass through 
the placenta. Also, the bacteria that produce the vitamin 
in the newborn’s intestines are not yet present. Breast 
milk contains only low levels of vitamin K, and it may 
take weeks to months for the infant’s ‘sterile’ gut to 
become established and functional. Infants are therefore 
predisposed to having low vitamin K levels, resulting in 
low levels of vitamin K-dependent clotting factors, and an 
increased risk for bleeding, termed vitamin K deficiency 
bleeding.
What is vitamin K deficiency 
bleeding (VKDB)?
Infants who do not receive the vitamin K shot are at risk  
for developing VKDB.
VKDB can be classified according to the time of 
presentation after birth into early (0–24 hours), classical 
(1–7 days) and late (2–12 weeks) VKDB. Early VKDB is 
severe, and is mainly found in infants whose mothers used 
certain medications during pregnancy that interfere with 
vitamin K metabolism, such as certain anticonvulsants 
or isoniazid. Classical VKDB is typically characterized by 
bruising or bleeding from the umbilicus. Late VKDB is the 
most concerning type — this bleeding occurs up to 6 
months of age in previously healthy infants, and between 
30–60% of late VKDB presents as an intracranial bleed. This 
life-threatening complication tends to occur in exclusively 
breastfed infants who have received no or inadequate 
vitamin K prophylaxis; warning bleeds before an initial 
severe event are rare.
Infants who do not get the vitamin K shot at birth are at 
81 times greater risk for developing VKDB than infants 
who do get the shot. VKDB is effectively prevented by 
the vitamin K shot — incidence of late VKDB, the most 
concerning type, falls to less than 1/100,000 infants when 
vitamin K is given at birth.
What are the warning signs of VKDB?
In the majority of cases of VKDB, there are NO WARNING SIGNS 
at all before a life-threatening bleed occurs. Infants who do not 
get vitamin K at birth might develop any of these signs of VKDB:
 y Bulging fontanelles
 y Diffused bruising and ecchymosis
 y Feeding intolerance, irritabilities
 y Epistaxis
 y Jaundice and pallor 
How can I prevent VKDB?
Make sure all newborns receive vitamin K prophylaxis. 
Administration of vitamin K (1 mg) after birth can prevent 
intracranial bleeding and other hemorrhagic manifestations.
Is Vitamin K safe?
A study from the early 1990’s found a possible link between 
intramuscular vitamin K administration and leukemia. Multiple 
follow-up studies did not confirm these findings. 
Where can I get more information?
For more information, please visit our website at: 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6245a4.htm 
http://www.cdc.gov/ncbddd/blooddisorders/index.html
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